- call +1-201-465-4211
- email sales@mrinsights.biz
According to this latest study, the 2021 growth of Rare Disease Genetic Testing will have significant change from previous year. By the most conservative estimates of global Rare Disease Genetic Testing market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Rare Disease Genetic Testing market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Rare Disease Genetic Testing market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Next-Generation Sequencing (NGS)
Array Technology
PCR-based Testing
Fluorescence in Situ Hybridization (FISH)
Sanger Sequencing
Karyotyping
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Research Laboratories and CROs
Diagnostic Laboratories
Hospitals and Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Quest Diagnostics
Centogene
Invitae Corporation
3billion
Arup Laboratories
Eurofins Scientific
Strand Life Sciences
Ambry Genetics
Perkin Elmer
Macrogen
Baylor Genetics
Color Genomics
Preventiongenetics
Progenity
Coopersurgical
Fulgent Genetics
Myriad Genetics
LabCorp
Opko Health
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rare Disease Genetic Testing Market Size 2016-2026
2.1.2 Rare Disease Genetic Testing Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Rare Disease Genetic Testing Segment by Type
2.2.1 Next-Generation Sequencing (NGS)
2.2.2 Next-Generation Sequencing (NGS)
2.2.3 PCR-based Testing
2.2.4 Fluorescence in Situ Hybridization (FISH)
2.2.5 Sanger Sequencing
2.2.6 Karyotyping
2.2.7 Others
2.3 Rare Disease Genetic Testing Market Size by Type
2.3.1 Global Rare Disease Genetic Testing Market Size CAGR by Type
2.3.2 Global Rare Disease Genetic Testing Market Size Market Share by Type (2016-2021)
2.4 Rare Disease Genetic Testing Segment by Application
2.4.1 Research Laboratories and CROs
2.4.2 Diagnostic Laboratories
2.4.3 Hospitals and Clinics
2.4.4 Others
2.5 Rare Disease Genetic Testing Market Size by Application
2.5.1 Global Rare Disease Genetic Testing Market Size CAGR by Application
2.5.2 Global Rare Disease Genetic Testing Market Size Market Share by Application (2016-2021)
3 Rare Disease Genetic Testing Market Size by Players
3.1 Rare Disease Genetic Testing Market Size Market Share by Players
3.1.1 Global Rare Disease Genetic Testing Revenue by Players (2019-2021E)
3.1.2 Global Rare Disease Genetic Testing Revenue Market Share by Players (2019-2021E)
3.2 Global Rare Disease Genetic Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Rare Disease Genetic Testing by Regions
4.1 Rare Disease Genetic Testing Market Size by Regions (2016-2021)
4.2 Americas Rare Disease Genetic Testing Market Size Growth (2016-2021)
4.3 APAC Rare Disease Genetic Testing Market Size Growth (2016-2021)
4.4 Europe Rare Disease Genetic Testing Market Size Growth (2016-2021)
4.5 Middle East & Africa Rare Disease Genetic Testing Market Size Growth (2016-2021)
5 Americas
5.1 Americas Rare Disease Genetic Testing Market Size by Country (2016-2021)
5.2 Americas Rare Disease Genetic Testing Market Size by Type (2016-2021)
5.3 Americas Rare Disease Genetic Testing Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rare Disease Genetic Testing Market Size by Region (2016-2021)
6.2 APAC Rare Disease Genetic Testing Market Size by Type (2016-2021)
6.3 APAC Rare Disease Genetic Testing Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Rare Disease Genetic Testing by Country (2016-2021)
7.2 Europe Rare Disease Genetic Testing Market Size by Type (2016-2021)
7.3 Europe Rare Disease Genetic Testing Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Rare Disease Genetic Testing by Region (2016-2021)
8.2 Middle East & Africa Rare Disease Genetic Testing Market Size by Type (2016-2021)
8.3 Middle East & Africa Rare Disease Genetic Testing Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Rare Disease Genetic Testing Market Forecast
10.1 Global Rare Disease Genetic Testing Forecast by Regions (2021-2026)
10.1.1 Global Rare Disease Genetic Testing Forecast by Regions (2021-2026)
10.1.2 Americas Rare Disease Genetic Testing Forecast
10.1.3 APAC Rare Disease Genetic Testing Forecast
10.1.4 Europe Rare Disease Genetic Testing Forecast
10.1.5 Middle East & Africa Rare Disease Genetic Testing Forecast
10.2 Americas Rare Disease Genetic Testing Forecast by Countries (2021-2026)
10.2.1 United States Rare Disease Genetic Testing Market Forecast
10.2.2 Canada Rare Disease Genetic Testing Market Forecast
10.2.3 Mexico Rare Disease Genetic Testing Market Forecast
10.2.4 Brazil Rare Disease Genetic Testing Market Forecast
10.3 APAC Rare Disease Genetic Testing Forecast by Region (2021-2026)
10.3.1 China Rare Disease Genetic Testing Market Forecast
10.3.2 Japan Rare Disease Genetic Testing Market Forecast
10.3.3 Korea Rare Disease Genetic Testing Market Forecast
10.3.4 Southeast Asia Rare Disease Genetic Testing Market Forecast
10.3.5 India Rare Disease Genetic Testing Market Forecast
10.3.6 Australia Rare Disease Genetic Testing Market Forecast
10.4 Europe Rare Disease Genetic Testing Forecast by Country (2021-2026)
10.4.1 Germany Rare Disease Genetic Testing Market Forecast
10.4.2 France Rare Disease Genetic Testing Market Forecast
10.4.3 UK Rare Disease Genetic Testing Market Forecast
10.4.4 Italy Rare Disease Genetic Testing Market Forecast
10.4.5 Russia Rare Disease Genetic Testing Market Forecast
10.5 Middle East & Africa Rare Disease Genetic Testing Forecast by Region (2021-2026)
10.5.1 Egypt Rare Disease Genetic Testing Market Forecast
10.5.2 South Africa Rare Disease Genetic Testing Market Forecast
10.5.3 Israel Rare Disease Genetic Testing Market Forecast
10.5.4 Turkey Rare Disease Genetic Testing Market Forecast
10.5.5 GCC Countries Rare Disease Genetic Testing Market Forecast
10.6 Global Rare Disease Genetic Testing Forecast by Type (2021-2026)
10.8 Global Rare Disease Genetic Testing Forecast by Application (2021-2026)
11 Key Players Analysis
11.1 Quest Diagnostics
11.1.1 Quest Diagnostics Company Information
11.1.2 Quest Diagnostics Rare Disease Genetic Testing Product Offered
11.1.3 Quest Diagnostics Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Quest Diagnostics Main Business Overview
11.1.5 Quest Diagnostics Latest Developments
11.2 Centogene
11.2.1 Centogene Company Information
11.2.2 Centogene Rare Disease Genetic Testing Product Offered
11.2.3 Centogene Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Centogene Main Business Overview
11.2.5 Centogene Latest Developments
11.3 Invitae Corporation
11.3.1 Invitae Corporation Company Information
11.3.2 Invitae Corporation Rare Disease Genetic Testing Product Offered
11.3.3 Invitae Corporation Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Invitae Corporation Main Business Overview
11.3.5 Invitae Corporation Latest Developments
11.4 3billion
11.4.1 3billion Company Information
11.4.2 3billion Rare Disease Genetic Testing Product Offered
11.4.3 3billion Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 3billion Main Business Overview
11.4.5 3billion Latest Developments
11.5 Arup Laboratories
11.5.1 Arup Laboratories Company Information
11.5.2 Arup Laboratories Rare Disease Genetic Testing Product Offered
11.5.3 Arup Laboratories Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Arup Laboratories Main Business Overview
11.5.5 Arup Laboratories Latest Developments
11.6 Eurofins Scientific
11.6.1 Eurofins Scientific Company Information
11.6.2 Eurofins Scientific Rare Disease Genetic Testing Product Offered
11.6.3 Eurofins Scientific Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Eurofins Scientific Main Business Overview
11.6.5 Eurofins Scientific Latest Developments
11.7 Strand Life Sciences
11.7.1 Strand Life Sciences Company Information
11.7.2 Strand Life Sciences Rare Disease Genetic Testing Product Offered
11.7.3 Strand Life Sciences Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Strand Life Sciences Main Business Overview
11.7.5 Strand Life Sciences Latest Developments
11.8 Ambry Genetics
11.8.1 Ambry Genetics Company Information
11.8.2 Ambry Genetics Rare Disease Genetic Testing Product Offered
11.8.3 Ambry Genetics Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Ambry Genetics Main Business Overview
11.8.5 Ambry Genetics Latest Developments
11.9 Perkin Elmer
11.9.1 Perkin Elmer Company Information
11.9.2 Perkin Elmer Rare Disease Genetic Testing Product Offered
11.9.3 Perkin Elmer Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Perkin Elmer Main Business Overview
11.9.5 Perkin Elmer Latest Developments
11.10 Macrogen
11.10.1 Macrogen Company Information
11.10.2 Macrogen Rare Disease Genetic Testing Product Offered
11.10.3 Macrogen Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Macrogen Main Business Overview
11.10.5 Macrogen Latest Developments
11. Baylor Genetics
11.11.1 Baylor Genetics Company Information
11.11.2 Baylor Genetics Rare Disease Genetic Testing Product Offered
11.11.3 Baylor Genetics Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Baylor Genetics Main Business Overview
11.11.5 Baylor Genetics Latest Developments
11.12 Color Genomics
11.12.1 Color Genomics Company Information
11.12.2 Color Genomics Rare Disease Genetic Testing Product Offered
11.12.3 Color Genomics Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 Color Genomics Main Business Overview
11.12.5 Color Genomics Latest Developments
11.13 Preventiongenetics
11.13.1 Preventiongenetics Company Information
11.13.2 Preventiongenetics Rare Disease Genetic Testing Product Offered
11.13.3 Preventiongenetics Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 Preventiongenetics Main Business Overview
11.13.5 Preventiongenetics Latest Developments
11.14 Progenity
11.14.1 Progenity Company Information
11.14.2 Progenity Rare Disease Genetic Testing Product Offered
11.14.3 Progenity Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 Progenity Main Business Overview
11.14.5 Progenity Latest Developments
11.15 Coopersurgical
11.15.1 Coopersurgical Company Information
11.15.2 Coopersurgical Rare Disease Genetic Testing Product Offered
11.15.3 Coopersurgical Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
11.15.4 Coopersurgical Main Business Overview
11.15.5 Coopersurgical Latest Developments
11.16 Fulgent Genetics
11.16.1 Fulgent Genetics Company Information
11.16.2 Fulgent Genetics Rare Disease Genetic Testing Product Offered
11.16.3 Fulgent Genetics Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
11.16.4 Fulgent Genetics Main Business Overview
11.16.5 Fulgent Genetics Latest Developments
11.17 Myriad Genetics
11.17.1 Myriad Genetics Company Information
11.17.2 Myriad Genetics Rare Disease Genetic Testing Product Offered
11.17.3 Myriad Genetics Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
11.17.4 Myriad Genetics Main Business Overview
11.17.5 Myriad Genetics Latest Developments
11.18 LabCorp
11.18.1 LabCorp Company Information
11.18.2 LabCorp Rare Disease Genetic Testing Product Offered
11.18.3 LabCorp Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
11.18.4 LabCorp Main Business Overview
11.18.5 LabCorp Latest Developments
11.19 Opko Health
11.19.1 Opko Health Company Information
11.19.2 Opko Health Rare Disease Genetic Testing Product Offered
11.19.3 Opko Health Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
11.19.4 Opko Health Main Business Overview
11.19.5 Opko Health Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Rare Disease Genetic Testing Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Next-Generation Sequencing (NGS)
Table 3. Major Players of Array Technology
Table 4. Major Players of PCR-based Testing
Table 5. Major Players of Fluorescence in Situ Hybridization (FISH)
Table 6. Major Players of Sanger Sequencing
Table 7. Major Players of Karyotyping
Table 8. Major Players of Others
Table 9. Rare Disease Genetic Testing Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 10. Global Rare Disease Genetic Testing Market Size by Type (2016-2021) & ($ Millions)
Table 11. Global Rare Disease Genetic Testing Market Size Market Share by Type (2016-2021)
Table 12. Rare Disease Genetic Testing Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 13. Global Rare Disease Genetic Testing Market Size by Application (2016-2021) & ($ Millions)
Table 14. Global Rare Disease Genetic Testing Market Size Market Share by Application (2016-2021)
Table 15. Global Rare Disease Genetic Testing Revenue by Players (2019-2021E) & ($ Millions)
Table 16. Global Rare Disease Genetic Testing Revenue Market Share by Players (2019-2021E)
Table 17. Rare Disease Genetic Testing Key Players Head office and Products Offered
Table 18. Rare Disease Genetic Testing Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Rare Disease Genetic Testing Market Size by Regions 2016-2021 & ($ Millions)
Table 22. Global Rare Disease Genetic Testing Market Size Market Share by Regions 2016-2021
Table 23. Americas Rare Disease Genetic Testing Market Size by Country (2016-2021) & ($ Millions)
Table 24. Americas Rare Disease Genetic Testing Market Size Market Share by Country (2016-2021)
Table 25. Americas Rare Disease Genetic Testing Market Size by Type (2016-2021) & ($ Millions)
Table 26. Americas Rare Disease Genetic Testing Market Size Market Share by Type (2016-2021)
Table 27. Americas Rare Disease Genetic Testing Market Size by Application (2016-2021) & ($ Millions)
Table 28. Americas Rare Disease Genetic Testing Market Size Market Share by Application (2016-2021)
Table 29. APAC Rare Disease Genetic Testing Market Size by Region (2016-2021) & ($ Millions)
Table 30. APAC Rare Disease Genetic Testing Market Size Market Share by Region (2016-2021)
Table 31. APAC Rare Disease Genetic Testing Market Size by Type (2016-2021) & ($ Millions)
Table 32. APAC Rare Disease Genetic Testing Market Size Market Share by Type (2016-2021)
Table 33. APAC Rare Disease Genetic Testing Market Size by Application (2016-2021) & ($ Millions)
Table 34. APAC Rare Disease Genetic Testing Market Size Market Share by Application (2016-2021)
Table 35. Europe Rare Disease Genetic Testing Market Size by Country (2016-2021) & ($ Millions)
Table 36. Europe Rare Disease Genetic Testing Market Size Market Share by Country (2016-2021)
Table 37. Europe Rare Disease Genetic Testing Market Size by Type (2016-2021) & ($ Millions)
Table 38. Europe Rare Disease Genetic Testing Market Size Market Share by Type (2016-2021)
Table 39. Europe Rare Disease Genetic Testing Market Size by Application (2016-2021) & ($ Millions)
Table 40. Europe Rare Disease Genetic Testing Market Size Market Share by Application (2016-2021)
Table 41. Middle East & Africa Rare Disease Genetic Testing Market Size by Region (2016-2021) & ($ Millions)
Table 42. Middle East & Africa Rare Disease Genetic Testing Market Size Market Share by Region (2016-2021)
Table 43. Middle East & Africa Rare Disease Genetic Testing Market Size by Type (2016-2021) & ($ Millions)
Table 44. Middle East & Africa Rare Disease Genetic Testing Market Size Market Share by Type (2016-2021)
Table 45. Middle East & Africa Rare Disease Genetic Testing Market Size by Application (2016-2021) & ($ Millions)
Table 46. Middle East & Africa Rare Disease Genetic Testing Market Size Market Share by Application (2016-2021)
Table 47. Key and Potential Regions of Rare Disease Genetic Testing
Table 48. Key Application and Potential Industries of Rare Disease Genetic Testing
Table 49. Key Challenges of Rare Disease Genetic Testing
Table 50. Key Trends of Rare Disease Genetic Testing
Table 51. Global Rare Disease Genetic Testing Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 52. Global Rare Disease Genetic Testing Market Size Market Share Forecast by Regions (2021-2026)
Table 53. Global Rare Disease Genetic Testing Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 54. Global Rare Disease Genetic Testing Market Size Market Share Forecast by Type (2021-2026)
Table 55. Global Rare Disease Genetic Testing Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 56. Global Rare Disease Genetic Testing Market Size Market Share Forecast by Application (2021-2026)
Table 57. Quest Diagnostics Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 58. Quest Diagnostics Rare Disease Genetic Testing Product Offered
Table 59. Quest Diagnostics Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 60. Quest Diagnostics Main Business
Table 61. Quest Diagnostics Latest Developments
Table 62. Centogene Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 63. Centogene Rare Disease Genetic Testing Product Offered
Table 64. Centogene Main Business
Table 65. Centogene Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 66. Centogene Latest Developments
Table 67. Invitae Corporation Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 68. Invitae Corporation Rare Disease Genetic Testing Product Offered
Table 69. Invitae Corporation Main Business
Table 70. Invitae Corporation Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 71. Invitae Corporation Latest Developments
Table 72. 3billion Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 73. 3billion Rare Disease Genetic Testing Product Offered
Table 74. 3billion Main Business
Table 75. 3billion Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 76. 3billion Latest Developments
Table 77. Arup Laboratories Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 78. Arup Laboratories Rare Disease Genetic Testing Product Offered
Table 79. Arup Laboratories Main Business
Table 80. Arup Laboratories Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 81. Arup Laboratories Latest Developments
Table 82. Eurofins Scientific Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 83. Eurofins Scientific Rare Disease Genetic Testing Product Offered
Table 84. Eurofins Scientific Main Business
Table 85. Eurofins Scientific Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 86. Eurofins Scientific Latest Developments
Table 87. Strand Life Sciences Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 88. Strand Life Sciences Rare Disease Genetic Testing Product Offered
Table 89. Strand Life Sciences Main Business
Table 90. Strand Life Sciences Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 91. Strand Life Sciences Latest Developments
Table 92. Ambry Genetics Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 93. Ambry Genetics Rare Disease Genetic Testing Product Offered
Table 94. Ambry Genetics Main Business
Table 95. Ambry Genetics Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 96. Ambry Genetics Latest Developments
Table 97. Perkin Elmer Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 98. Perkin Elmer Rare Disease Genetic Testing Product Offered
Table 99. Perkin Elmer Main Business
Table 100. Perkin Elmer Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 101. Perkin Elmer Latest Developments
Table 102. Macrogen Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 103. Macrogen Rare Disease Genetic Testing Product Offered
Table 104. Macrogen Main Business
Table 105. Macrogen Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 106. Macrogen Latest Developments
Table 107. Baylor Genetics Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 108. Baylor Genetics Rare Disease Genetic Testing Product Offered
Table 109. Baylor Genetics Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 110. Baylor Genetics Main Business
Table 111. Baylor Genetics Latest Developments
Table 112. Color Genomics Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 113. Color Genomics Rare Disease Genetic Testing Product Offered
Table 114. Color Genomics Main Business
Table 115. Color Genomics Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 116. Color Genomics Latest Developments
Table 117. Preventiongenetics Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 118. Preventiongenetics Rare Disease Genetic Testing Product Offered
Table 119. Preventiongenetics Main Business
Table 120. Preventiongenetics Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 121. Preventiongenetics Latest Developments
Table 122. Progenity Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 123. Progenity Rare Disease Genetic Testing Product Offered
Table 124. Progenity Main Business
Table 125. Progenity Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 126. Progenity Latest Developments
Table 127. Coopersurgical Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 128. Coopersurgical Rare Disease Genetic Testing Product Offered
Table 129. Coopersurgical Main Business
Table 130. Coopersurgical Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 131. Coopersurgical Latest Developments
Table 132. Fulgent Genetics Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 133. Fulgent Genetics Rare Disease Genetic Testing Product Offered
Table 134. Fulgent Genetics Main Business
Table 135. Fulgent Genetics Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 136. Fulgent Genetics Latest Developments
Table 137. Myriad Genetics Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 138. Myriad Genetics Rare Disease Genetic Testing Product Offered
Table 139. Myriad Genetics Main Business
Table 140. Myriad Genetics Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 141. Myriad Genetics Latest Developments
Table 142. LabCorp Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 143. LabCorp Rare Disease Genetic Testing Product Offered
Table 144. LabCorp Main Business
Table 145. LabCorp Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 146. LabCorp Latest Developments
Table 147. Opko Health Details, Company Type, Rare Disease Genetic Testing Area Served and Its Competitors
Table 148. Opko Health Rare Disease Genetic Testing Product Offered
Table 149. Opko Health Main Business
Table 150. Opko Health Rare Disease Genetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 151. Opko Health Latest Developments
List of Figures
Figure 1. Rare Disease Genetic Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Rare Disease Genetic Testing Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Rare Disease Genetic Testing Market Size Market Share by Type in 2020
Figure 7. Rare Disease Genetic Testing in Research Laboratories and CROs
Figure 8. Global Rare Disease Genetic Testing Market: Research Laboratories and CROs (2016-2021) & ($ Millions)
Figure 9. Rare Disease Genetic Testing in Diagnostic Laboratories
Figure 10. Global Rare Disease Genetic Testing Market: Diagnostic Laboratories (2016-2021) & ($ Millions)
Figure 11. Rare Disease Genetic Testing in Hospitals and Clinics
Figure 12. Global Rare Disease Genetic Testing Market: Hospitals and Clinics (2016-2021) & ($ Millions)
Figure 13. Rare Disease Genetic Testing in Others
Figure 14. Global Rare Disease Genetic Testing Market: Others (2016-2021) & ($ Millions)
Figure 15. Global Rare Disease Genetic Testing Market Size Market Share by Application in 2020
Figure 16. Global Rare Disease Genetic Testing Revenue Market Share by Player in 2020
Figure 17. Global Rare Disease Genetic Testing Market Size Market Share by Regions (2016-2021)
Figure 18. Americas Rare Disease Genetic Testing Market Size 2016-2021 ($ Millions)
Figure 19. APAC Rare Disease Genetic Testing Market Size 2016-2021 ($ Millions)
Figure 20. Europe Rare Disease Genetic Testing Market Size 2016-2021 ($ Millions)
Figure 21. Middle East & Africa Rare Disease Genetic Testing Market Size 2016-2021 ($ Millions)
Figure 22. Americas Rare Disease Genetic Testing Market Size Market Share by Country in 2020
Figure 23. Americas Rare Disease Genetic Testing Market Size Market Share by Type in 2020
Figure 24. Americas Rare Disease Genetic Testing Market Size Market Share by Application in 2020
Figure 25. United States Rare Disease Genetic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 26. Canada Rare Disease Genetic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 27. Mexico Rare Disease Genetic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 28. APAC Rare Disease Genetic Testing Market Size Market Share by Regions in 2020
Figure 29. APAC Rare Disease Genetic Testing Market Size Market Share by Type in 2020
Figure 30. APAC Rare Disease Genetic Testing Market Size Market Share by Application in 2020
Figure 31. China Rare Disease Genetic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 32. Japan Rare Disease Genetic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 33. Korea Rare Disease Genetic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 34. Southeast Asia Rare Disease Genetic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 35. India Rare Disease Genetic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 36. Australia Rare Disease Genetic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 37. Europe Rare Disease Genetic Testing Market Size Market Share by Country in 2020
Figure 38. Europe Rare Disease Genetic Testing Market Size Market Share by Type in 2020
Figure 39. Europe Rare Disease Genetic Testing Market Size Market Share by Application in 2020
Figure 40. Germany Rare Disease Genetic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 41. France Rare Disease Genetic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 42. UK Rare Disease Genetic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 43. Italy Rare Disease Genetic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 44. Russia Rare Disease Genetic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 45. Middle East & Africa Rare Disease Genetic Testing Market Size Market Share by Region in 2020
Figure 46. Middle East & Africa Rare Disease Genetic Testing Market Size Market Share by Type in 2020
Figure 47. Middle East & Africa Rare Disease Genetic Testing Market Size Market Share by Application in 2020
Figure 48. Egypt Rare Disease Genetic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 49. South Africa Rare Disease Genetic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 50. Israel Rare Disease Genetic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 51. Turkey Rare Disease Genetic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 52. GCC Country Rare Disease Genetic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 53. Americas Rare Disease Genetic Testing Market Size 2021-2026 ($ Millions)
Figure 54. APAC Rare Disease Genetic Testing Market Size 2021-2026 ($ Millions)
Figure 55. Europe Rare Disease Genetic Testing Market Size 2021-2026 ($ Millions)
Figure 56. Middle East & Africa Rare Disease Genetic Testing Market Size 2021-2026 ($ Millions)
Figure 57. United States Rare Disease Genetic Testing Market Size 2021-2026 ($ Millions)
Figure 58. Canada Rare Disease Genetic Testing Market Size 2021-2026 ($ Millions)
Figure 59. Mexico Rare Disease Genetic Testing Market Size 2021-2026 ($ Millions)
Figure 60. Brazil Rare Disease Genetic Testing Market Size 2021-2026 ($ Millions)
Figure 61. China Rare Disease Genetic Testing Market Size 2021-2026 ($ Millions)
Figure 62. Japan Rare Disease Genetic Testing Market Size 2021-2026 ($ Millions)
Figure 63. Korea Rare Disease Genetic Testing Market Size 2021-2026 ($ Millions)
Figure 64. Southeast Asia Rare Disease Genetic Testing Market Size 2021-2026 ($ Millions)
Figure 65. India Rare Disease Genetic Testing Market Size 2021-2026 ($ Millions)
Figure 66. Australia Rare Disease Genetic Testing Market Size 2021-2026 ($ Millions)
Figure 67. Germany Rare Disease Genetic Testing Market Size 2021-2026 ($ Millions)
Figure 68. France Rare Disease Genetic Testing Market Size 2021-2026 ($ Millions)
Figure 69. UK Rare Disease Genetic Testing Market Size 2021-2026 ($ Millions)
Figure 70. Italy Rare Disease Genetic Testing Market Size 2021-2026 ($ Millions)
Figure 71. Russia Rare Disease Genetic Testing Market Size 2021-2026 ($ Millions)
Figure 72. Spain Rare Disease Genetic Testing Market Size 2021-2026 ($ Millions)
Figure 73. Egypt Rare Disease Genetic Testing Market Size 2021-2026 ($ Millions)
Figure 74. South Africa Rare Disease Genetic Testing Market Size 2021-2026 ($ Millions)
Figure 75. Israel Rare Disease Genetic Testing Market Size 2021-2026 ($ Millions)
Figure 76. Turkey Rare Disease Genetic Testing Market Size 2021-2026 ($ Millions)
Figure 77. GCC Country Rare Disease Genetic Testing Market Size 2021-2026 ($ Millions)
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
